Okay, let's tackle this question about hyperparathyroidism and its bony changes. First, I need to recall the core concept. Hyperparathyroidism, especially primary, leads to increased parathyroid hormone (PTH) levels. PTH affects bone metabolism by stimulating osteoclast activity, leading to bone resorption.

Now, the correct answer here is likely to be subperiosteal resorption or other classic features like brown tumors or osteitis fibrosa cystica. Let me think about the options. The question isn't providing the options, but common bony changes in hyperparathyroidism include subperiosteal resorption, especially in the phalanges, and also in the skull (peaked skull), subperiosteal bone resorption in the distal radius, and possibly brown tumors. Osteitis fibrosa cystica is another term for the skeletal changes due to excessive PTH.

For the wrong options, maybe they list other conditions like osteoporosis from other causes, or features of hypoparathyroidism. For example, osteomalacia or Paget's disease might be distractors. Also, hyperparathyroidism doesn't cause increased bone density, so if an option mentions that, it's incorrect.

Clinical pearls: Remember that hyperparathyroidism's bony changes are due to increased osteoclast activity. Brown tumors are a hallmark, and subperiosteal resorption is classic. Osteitis fibrosa cystica is the term for the bone disease in primary hyperparathyroidism.

Putting it all together, the correct answer would be the one that refers to subperiosteal resorption, osteitis fibrosa cystica, or brown tumors. The other options might be related to other conditions or incorrect manifestations.

**Core Concept**
Hyperparathyroidism, particularly **primary hyperparathyroidism**, causes **osteitis fibrosa cystica**, characterized by **bone resorption** due to excessive **parathyroid hormone (PTH)**. PTH activates osteoclasts via the **RANKL pathway**, leading to increased bone turnover and characteristic skeletal changes.

**Why the Correct Answer is Right**
The correct answer refers to **subperiosteal bone resorption** and **brown tumors**. Elevated PTH increases osteoclast activity, causing **fibroblast growth factor 23 (FGF-23)** release, which impairs renal phosphate reabsorption. Bone resorption leads to **osteitis fibrosa cystica**, with subperiosteal resorption in phalanges/radius and brown tumors (fibrous cysts filled with hemosiderin). These changes reflect **PTH-driven osteoclastic activity** and **phosphate-wasting**.

**Why Each Wrong Option is Incorrect**
**Option A:** *Osteosclerosis* (increased bone density) is incorrect. Hyperparathyroidism causes **osteopenia/osteoporosis**, not sclerosis.
**Option B:** *Osteomalacia* (impaired mineralization) is linked to **vitamin D deficiency**, not PTH excess.
**Option C:** *Paget’s disease* features disorganized bone remodeling due to **abnormal osteoclast function**, unrelated to PTH.
**Option D:** *Osteoporosis without resorption** (e.g.,

✓ Correct Answer: D. All of the above